About
Overview
Leadership
Pipeline
Overview
ONCT-808
ONCT-534
Zilovertamab
Science
Overview
Publications
Investors
Overview
News Releases
Events & Presentations
Financial Reports
Stock Information
Analyst Coverage
Corporate Governance
Patients
Careers
Current Opportunities
Vision, Mission and Impact
Contact
Anti-ROR1 CAR-T Cells: Architecture and Performance (Daniel Andrés Osorio-Rodríguez, Bernardo Armando Camacho, César Ramírez-Segura Front Med (Lausanne). 2023; 10: 1121020)
Please ensure Javascript is enabled for purposes of
website accessibility
About
Overview
Leadership
Pipeline
Overview
ONCT-808
ONCT-534
Zilovertamab
Science
Overview
Publications
Investors
Overview
News Releases
Events & Presentations
Financial Reports
Stock Information
Analyst Coverage
Corporate Governance
Patients
Careers
Current Opportunities
Vision, Mission and Impact
Contact